Wed, Aug 20, 2014, 6:57 PM EDT - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

Galena Biopharma, Inc. Message Board

  • bushcostinks bushcostinks Feb 22, 2013 12:21 PM Flag

    Were we hurt by this news ?

    I still think GALE has a better drug as the research proves.........But $9800 a month is a huge nut to swallow.

    The Food and Drug Administration on Friday approved a new type of drug that combines the widely used breast cancer medicine Herceptin with a powerful toxin to more effectively kill cancer cells while potentially reducing side effects.

    The drug, which will be called Kadcyla but was known as T-DM1 during its development, extended the median survival of women with advanced breast cancer by nearly half a year in a clinical trial.

    Genentech, which developed the drug, said it would cost about $9,800 a month, or $94,000 for a typical course of treatment.

    Sentiment: Buy

    SortNewest  |  Oldest  |  Most Replied Expand all replies
 
GALE
2.32-0.01(-0.43%)Aug 20 4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.